背景:与髋关节骨关节炎相关的卫生服务利用给社会和卫生保健系统带来了巨大的负担。我们的目的是根据全国数据分析匈牙利髋关节骨关节炎的流行病学和健康保险疾病负担。
方法:数据来自匈牙利国家健康保险基金管理局(NHIFA)2018年的全国金融数据库。分析的数据包括年度患者人数,患病率,门诊护理中每10万人的年龄标准化患病率,为所有类型的护理按年龄组和性别计算的健康保险费用。使用国际疾病分类(ICD)的代码M16鉴定髋骨关节炎患者,第十次修订。使用欧洲标准人群2013(ESP2013)计算年龄标准化患病率。
结果:根据门诊护理的患者人数,男性中每10万人的患病率为1,483.7例(1.5%),女性中2,905.5(2.9%),共有2,226.2例患者(2.2%)。每100,000人口中,男性的年龄标准化患病率为1,734.8(1.7%),女性为2,594.8(2.6%),总计2,237.6(2.2%)。所有年龄组的妇女每100,000人的患病率更高。在30-39岁、40-49岁、50-59岁、60-69岁和70岁以上年龄组中,总患病率为0.2%,0.8%,2.7%,5.0%和7.7%,分别,描述了一种持续增长的趋势。2018年,NHIFA花费了4231万欧元用于治疗髋关节骨关节炎。髋关节骨性关节炎占全国医疗保险总支出的1%。36.8%的费用归因于男性患者的治疗,女性患者占63.2%。急性住院护理,门诊护理和慢性和康复住院护理是主要的成本驱动因素,占62.7%,男性医疗总支出的14.6%和8.2%,51.0%,女性为20.0%和11.2%,分别。每位患者的平均年治疗费用为男性3,627欧元,女性4,194欧元。
结论:与男性相比,女性髋关节骨性关节炎的患病率高1.96倍(年龄标准化患病率高1.5倍)。急性住院护理是治疗髋关节骨关节炎的主要成本驱动因素。女性患者的平均年治疗费用比男性高15.6%。
BACKGROUND: Health services utilization related to hip osteoarthritis imposes a significant burden on society and health care systems. Our aim was to analyse the epidemiological and health insurance disease burden of hip osteoarthritis in Hungary based on nationwide data.
METHODS: Data were extracted from the nationwide financial database of the National Health Insurance Fund Administration (NHIFA) of Hungary for the year 2018. The analysed data included annual patient numbers, prevalence, and age-standardized prevalence per 100,000 population in outpatient care, health insurance costs calculated for age groups and sexes for all types of care. Patients with hip osteoarthritis were identified using code M16 of the International Classification of Diseases (ICD), 10th revision. Age-standardised prevalence rates were calculated using the European Standard Population 2013 (ESP2013).
RESULTS: Based on patient numbers of outpatient care, the prevalence per 100,000 among males was 1,483.7 patients (1.5%), among females 2,905.5 (2.9%), in total 2,226.2 patients (2.2%). The age-standardised prevalence was 1,734.8 (1.7%) for males and 2,594.8 (2.6%) for females per 100,000 population, for a total of 2,237.6 (2.2%). The prevalence per 100,000 population was higher for women in all age groups. In age group 30-39, 40-49, 50-59, 60-69 and 70 + the overall prevalence was 0.2%, 0.8%, 2.7%, 5.0% and 7.7%, respectively, describing a continuously increasing trend. In 2018, the NHIFA spent 42.31 million EUR on the treatment of hip osteoarthritis. Hip osteoarthritis accounts for 1% of total nationwide health insurance expenditures. 36.8% of costs were attributed to the treatment of male patients, and 63.2% to female patients. Acute inpatient care, outpatient care and chronic and rehabilitation inpatient care were the main cost drivers, accounting for 62.7%, 14.6% and 8.2% of the total health care expenditure for men, and 51.0%, 20.0% and 11.2% for women, respectively. The average annual treatment cost per patient was 3,627 EUR for men and 4,194 EUR for women.
CONCLUSIONS: The prevalence of hip osteoarthritis was 1.96 times higher (the age-standardised prevalence was 1.5 times higher) in women compared to men. Acute inpatient care was the major cost driver in the treatment of hip osteoarthritis. The average annual treatment cost per patient was 15.6% higher for women compared to men.